ESI hospital to constitute committee to study high COVID-19 mortality rate

Stating that the Mortality rate is as high as 12.8% and there is a need to understand the reason, Medical Education Minister Dr K Sudhakar said that more number of cancer patients are getting admitted into this hospital.

Published On 2020-08-10 11:45 GMT   |   Update On 2020-08-10 11:45 GMT
Advertisement

Bengaluru: A committee will be formed to study the reasons for the high mortality of COVID patients in ESI hospital, located in the city, Medical Education Minister Dr K Sudhakar said here on Saturday.

Speaking to newsmen after visiting the Hospital, the Minister said that ever since the onset of the COVID-19 disease as many as 421 patients had been admitted to the ESI hospital and 54 of them succumbed to the pandemic.

Advertisement

Read Also: COVID outbreak: HAL donates 2 ambulances to Bengaluru hospital

Stating that the Mortality rate is as high as 12.8% and there is a need to understand the reason, he said that more number of cancer patients are getting admitted into this hospital.

"Patients are coming to hospital often at later stages of infection which is also may be a reason for the high mortality rate" he said.

However, a death audit has been ordered and the same will be submitted to the government, he said.

The Minister also informed that there are 494 beds in this hospital and 150 beds have been reserved for Covid patients. Two patients are in serious condition and 10 are in ICU.

The Minister, who had also held an interaction with the patients, through video conference, informed that Patients have expressed satisfaction about the treatment and other facilities here. Doctors and PG students are working hard to control the pandemic, the Minister said.

Read Also: Mangaluru: Private hospitals to reserve 50 percent beds for Coronavirus treatment

Tags:    
Article Source : UNI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News